§ EQUITY
USDGYRE
GYRE THERAPEUTICS INC
USD
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 984K | 0.0% | n/a |
| VANGUARD CAPITAL MANAGEMENT LLC | 984K | 0.0% | n/a |
| BlackRock, Inc. | 377K | 0.0% | +5% |
| Geode Capital Management | 367K | 0.0% | +2% |
| BlackRock, Inc. | 320K | 0.0% | n/a |
| State Street | 216K | 0.0% | +7% |
◇ AC INTELLIGENCE
Top institutional owners for GYRE as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER54.8% · 27 holders
PASSIVE / INDEX31.3% · 6 holders
DEALER / BANK12.2% · 15 holders
QUALITY / COMPOUNDER1.5% · 4 holders
INCOME / DEFENSIVE0.1% · 3 holders
SYSTEMATIC / QUANT0.0% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for GYRE in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention GYRE yet.